Dialysis should not sideline your life plans.

We are a team committed to improving the quality of life of dialysis patients through the focused commercialization of a fully implantable continuous hemodialysis device.

Over 500,000 patients in the US with end-stage renal disease on dialysis have an average life expectancy of only 5-10 years because of the complications associated with dialysis. A team of scientists and medical professionals have developed a patented, fully implantable continuous dialysis device, eliminating the need for ‘in-center’ dialysis thereby resulting in a better quality of life while also decreasing the costs associated dialysis care. The company has cleared several major design and development hurdles proving their device’s ability to clear waste products from blood and prevent blood clotting through their proprietary design - all moving towards bringing the device to market.

Quote from the team: “At Nephrodite, we envision a world where dialysis doesn't mean stopping your life. This is why our team is dedicated to developing and commercializing our fully implantable continuous dialysis device - The Holly. The Holly is a patent protected device in preclinical development that works while you do life without the need to spend your waking hours hooked up to externalized machines.”

KidneyBuzz.com Breakthrough Email List Team is here for you every step of the way and will continue to help you get listed on the preferred breakthroughs of your choosing, as possible.

This information is exclusive to you as a BREAKTHROUGH Email List Member. Please do not share or copy as it may result in your permanent ban from the list. If you have been informed that you are past due, please update your billing information here.

Reply “YES” if this is research you would like to be kept updated on as a member of the KidneyBuzz BREAKTHROUGH EMAIL LIST. Update your preferences by clicking here.

Courtesy KidneyBuzz Breakthrough Email List